A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Levofloxacin for the Treatment of Mild to Moderate Pneumonia in Adult Patients
Public ClinicalTrials.gov record NCT00643734. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Double-Dummy Comparative Trial of Azithromycin SR Versus Levofloxacin for the Treatment of Mild to Moderate Community-Acquired Pneumonia in Adults
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The study was performed to see if a single, 2.0-g oral dose of azithromycin sustained release (SR) was at least as effective as a 7-day regimen of levofloxacin (500 mg once daily) for the treatment of mild to moderate community-acquired pneumonia, and to assess the efficacy and safety of both treatment regimens.
Study identification
- NCT ID
- NCT00643734
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 468 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 2003 (Type not available)
- Primary completion
- Not listed
- Completion
- Apr 2004 (Actual)
- Last update posted
- Mar 26, 2008
2003 – 2004
United States locations
- U.S. sites
- 35
- U.S. states
- 23
- U.S. cities
- 31
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Mesa | Arizona | 85206 | — |
| Pfizer Investigational Site | Phoenix | Arizona | 85014 | — |
| Pfizer Investigational Site | San Luis Obispo | California | 93401 | — |
| Pfizer Investigational Site | San Mateo | California | 94403 | — |
| Pfizer Investigational Site | Highlands Ranch | Colorado | 80130 | — |
| Pfizer Investigational Site | Newark | Delaware | 19702 | — |
| Pfizer Investigational Site | Kissimmee | Florida | 34741 | — |
| Pfizer Investigational Site | Merrit Island | Florida | 32953 | — |
| Pfizer Investigational Site | Evansville | Indiana | 47712 | — |
| Pfizer Investigational Site | Evansville | Indiana | 47714 | — |
| Pfizer Investigational Site | Indianapolis | Indiana | 46254 | — |
| Pfizer Investigational Site | Dubuque | Iowa | 52001 | — |
| Pfizer Investigational Site | Pratt | Kansas | 67124 | — |
| Pfizer Investigational Site | Madisonville | Kentucky | 42431 | — |
| Pfizer Investigational Site | Cumberland | Maryland | 21502 | — |
| Pfizer Investigational Site | Kalamazoo | Michigan | 49009 | — |
| Pfizer Investigational Site | Olive Branch | Mississippi | 38654 | — |
| Pfizer Investigational Site | Elkhorn | Nebraska | 68022 | — |
| Pfizer Investigational Site | Omaha | Nebraska | 68144 | — |
| Pfizer Investigational Site | Rio Rancho | New Mexico | 87124 | — |
| Pfizer Investigational Site | Charlotte | North Carolina | 28209 | — |
| Pfizer Investigational Site | Charlotte | North Carolina | 28210 | — |
| Pfizer Investigational Site | Charlotte | North Carolina | 28262 | — |
| Pfizer Investigational Site | Hickory | North Carolina | 28601 | — |
| Pfizer Investigational Site | Yukon | Oklahoma | 73099 | — |
| Pfizer Investigational Site | Downingtown | Pennsylvania | 19335 | — |
| Pfizer Investigational Site | King of Prussia | Pennsylvania | 19406 | — |
| Pfizer Investigational Site | Morrisville | Pennsylvania | 19067 | — |
| Pfizer Investigational Site | Greer | South Carolina | 29651 | — |
| Pfizer Investigational Site | Dyersburg | Tennessee | 38024 | — |
| Pfizer Investigational Site | Lake Jackson | Texas | 77566 | — |
| Pfizer Investigational Site | Salt Lake City | Utah | 84109 | — |
| Pfizer Investigational Site | Salt Lake City | Utah | 84121 | — |
| Pfizer Investigational Site | Walla Walla | Washington | 99362 | — |
| Pfizer Investigational Site | Menomonee Falls | Wisconsin | 53051 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 30 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00643734, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 26, 2008 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00643734 live on ClinicalTrials.gov.